[1]
R. Bembry, N. Malakouti, and M. Maiberger, “Hypersensitivity Reactions Secondary to Dupilumab in Two Patients with Moderate to Severe Atopic Dermatitis”, J of Skin, vol. 4, no. 4, pp. 372–374, Jul. 2020.